StockData
biote Corp. logo

biote Corp. (BTMD) income statement

BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3069% below fair value
$0.89−0.10 (-10.51%)

Close on Nov 18, 2026Market cap $31.83MP/E 8.9Yield –

biote Corp. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
68.6%
Operating margin
8.0%
Net margin
3.2%
Return on equity, FY2025
-32.9%

Financial strength

Current ratio
1.43
Debt to equity
-1.85
Debt to assets
119.5%
Cash to current liabilities
37.1%

Valuation

P/E ratio
8.9
Price to sales
0.17
Price to book
–
Dividend yield
–

See a number that looks wrong?